Related references
Note: Only part of the references are listed.Heparin-mediated conformational changes in fibronectin expose vascular endothelial growth factor binding sites
Maria Mitsi et al.
BIOCHEMISTRY (2006)
Antithrombin-S195A factor Xa-heparin structure reveals the allosteric mechanism of antithrombin activation
Daniel J. D. Johnson et al.
EMBO JOURNAL (2006)
Effects of receptor clustering on ligand dissociation kinetics:: Theory and simulations
M Gopalakrishnan et al.
BIOPHYSICAL JOURNAL (2005)
Glycomics: an integrated systems approach to structure-function relationships of glycans
R Raman et al.
NATURE METHODS (2005)
Ligand rebinding:: self-consistent mean-field theory and numerical simulations applied to surface plasmon resonance studies
M Gopalakrishnan et al.
EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS (2005)
Degranulating mast cells in fibrotic regions of human tumors and evidence that mast cell heparin interferes with the growth of tumor cells through a mechanism involving fibroblasts
M Samoszuk et al.
BMC CANCER (2005)
Cellular signaling by fibroblast growth factor receptors
VP Eswarakumar et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2005)
Heparan sulfate-protein interactions: therapeutic potential through structure-function insights
DR Coombe et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2005)
Interactions of heparin/heparan sulfate with proteins: Appraisal of structural factors and epxerimental approaches
AK Powell et al.
GLYCOBIOLOGY (2004)
Fibronectin promotes VEGF-induced CD34+ cell differentiation into endothelial cells
ES Wijelath et al.
JOURNAL OF VASCULAR SURGERY (2004)
pH regulates vascular endothelial growth factor binding to fibronectin - A mechanism for control of extracellular matrix storage and release
AL Goerges et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
A method for the non-covalent immobilization of heparin to surfaces
DJ Mahoney et al.
ANALYTICAL BIOCHEMISTRY (2004)
Heparins and heparinoids: Occurrence, structure and mechanism of antithrombotic and hemorrhagic activities
HB Nader et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
Crystal structure of antithrombin in a heparin-bound intermediate state
DJD Johnson et al.
BIOCHEMISTRY (2003)
Regulation of vascular endothelial growth factor binding and activity by extracellular pH
AL Goerges et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Mapping the heparin-binding site on the 13-14F3 fragment of fibronectin
Sachchidanand et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Anticoagulants in cancer treatment: malignancy as a solid phase coagulopathy
LR Zacharski
CANCER LETTERS (2002)
Novel vascular endothelial growth factor binding domains of fibronectin enhance vascular endothelial growth factor biological activity
ES Wijelath et al.
CIRCULATION RESEARCH (2002)
VEGF165 requires extracellular matrix components to induce mitogenic effects and migratory response in breast cancer cells
T Miralem et al.
ONCOGENE (2001)
Integrin activation is required for VEGF and FGF receptor protein presence on human microvascular endothelial cells
R Tsou et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2001)
Heparin and heparan sulfate: biosynthesis, structure and function
R Sasisekharan et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2000)
Conformation and dynamics of heparin and heparan sulfate
B Mulloy et al.
GLYCOBIOLOGY (2000)
Regulation of angiogenesis in vivo by ligation of integrin α5β1 with the central cell-binding domain of fibronectin
S Kim et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Fibroblast growth factor-2
MA Nugent et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2000)
Share Paper
